Evidence map›Paper›PMID 25680196›Full record

ArticlePloS one2015

Assessment of dysmyelination with RAFFn MRI: application to murine MPS I.

David Satzer, Christina DiBartolomeo, Michael M Ritchie, Christine Storino, Timo Liimatainen, Hanne Hakkarainen, Djaudat Idiyatullin, Silvia Mangia, Shalom Michaeli, Ann M Parr and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. RJournal of magnetic resonance (San Diego, Calif. : 1997) · 2026
    Article
  3. Article
  4. Complete solution for rotating frame relaxation functions during adiabatic pulses.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

David SatzerDepartment of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, United States of America.
Christina DiBartolomeoDepartment of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, United States of America.
Michael M RitchieDepartment of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, United States of America.
Christine StorinoCenter of Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, United States of America.
Timo LiimatainenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Hanne HakkarainenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Djaudat IdiyatullinCenter of Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, United States of America.
Silvia MangiaCenter of Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, United States of America.
Shalom MichaeliCenter of Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, United States of America.
Ann M ParrDepartment of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, United States of America.
Walter C LowDepartment of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, United States of America.
University of Minnesota · USUniversity of Eastern Finland · FIResonance Research (United States) · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
THERAPY FOR HYPERAMMONEMIA WITH GENETICALLY ENGINEERED BACTERIAP01HD032652 · NICHD · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WHITLEY, CHESTER B. · 1995 to 2016
$14.5M
Neuroscience Cores For MR Studies of the BrainP30NS057091 · NINDS · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2006 to 2011
$8.5M
NMR Imaging and SpectroscopyP41EB015894 · NIBIB · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2012 to 2017
$8.4M
Institutional Career Development CoreKL2TR002492 · NCATS · UNIVERSITY OF MINNESOTA · PI INGBAR, DAVID H · 2018 to 2022
$6.3M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)KL2TR000113 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$5.4M
Institutional Center Cores for Advanced NeuroimagingP30NS076408 · NINDS · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2012 to 2020
$4.2M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)KL2RR033182 · NCRR · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2011 to 2011
$1.4M
Novel MRI Methods for Neuronal Loss and Iron Quantification in Parkinsons DiseaseR01NS061866 · NINDS · UNIVERSITY OF MINNESOTA · PI MICHAELI, SHALOM · 2008 to 2010
$988k
4 Tesla Human MRI/MRS Console UpgradeS10RR023730 · NCRR · UNIVERSITY OF MINNESOTA · PI GARWOOD, MICHAEL G · 2007 to 2007
$500k
High Performance Gradient and Shim System for a 4T Human MR ScannerS10RR027290 · NCRR · UNIVERSITY OF MINNESOTA · PI TKAC, IVAN · 2010 to 2010
$500k
NCATS NIH HHS KL2 TR000113NCATS NIH HHS KL2 TR002492NCATS NIH HHS UL1 TR000114NCATS NIH HHS UL1TR000114NCRR NIH HHS KL2 RR033182NCRR NIH HHS S10 RR023730NCRR NIH HHS S10 RR027290NIBIB NIH HHS P41 EB015894NICHD NIH HHS P01 HD032652NICHD NIH HHS P01HD032652NINDS NIH HHS P30 NS057091NINDS NIH HHS P30 NS076408NINDS NIH HHS R01 NS061866
6 · The paper itself

Abstract

Type I mucopolysaccharidosis (MPS I) is an autosomal recessive lysosomal storage disorder with neurological features. Humans and laboratory animals with MPS I exhibit various white matter abnormalities involving the corpus callosum and other regions. In this study, we first validated a novel MRI technique, entitled Relaxation Along a Fictitious Field in the rotating frame of rank n (RAFFn), as a measure of myelination and dysmyelination in mice. We then examined differences between MPS I mice and heterozygotes using RAFF5 and histology. RAFF5 (i.e., RAFFn with n = 5) relaxation time constants were highly correlated with histological myelin density (R2 = 0.68, P<0.001), and RAFF5 clearly distinguished between the hypomyelinated and dysmyelinated shiverer mouse and the wild-type mouse. Bloch-McConnell theoretical analysis revealed slower exchange correlation times and smaller exchange-induced relaxation rate constants for RAFF4 and RAFF5 compared to RAFF1-3, T1ρ, and T2ρ. These data suggest that RAFF5 may assess methylene protons in myelin lipids and proteins, though other mechanisms (e.g. detection of myelin-bound water) may also explain the sensitivity of RAFF5 to myelin. In MPS I mice, mean RAFF5 relaxation time constants were significantly larger for the striatum (P = 0.004) and internal capsule (P = 0.039), and marginally larger for the fornix (P = 0.15). Histological assessment revealed no differences between MPS I mice and heterozygotes in myelin density or corpus callosum thickness. Taken together, these findings support subtle dysmyelination in the brains of mice with MPS I. Dysmyelination may result from myelin lipid abnormalities caused by the absence of α-L-iduronidase. Our findings may help to explain locomotor and cognitive deficits seen in mice with MPS I.

Indexed as

RotationAnimalsCorpus CallosumFemaleHeterozygoteIduronidaseMagnetic Resonance ImagingMaleMiceMucopolysaccharidosis IMyelin SheathOrgan SizeTime FactorsIduronidase

Identifiers

PMID25680196
PMCPMC4334512
OpenAlexW2024617890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.